Skip to content
10-Q

Quarterly Report

THERAGENICS CORP

0001188112-12-002509

← back to feed
Filed
Aug 13, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2012 · Aug 6, 2012 29.98M sh
Short Term Debt Q2 2012 · Jun 30, 2012 $22M
Short Term Debt Q2 2012 · Dec 31, 2011 $23.67M
Stockholders Equity Q2 2012 · Jun 30, 2012 $86.42M
Stockholders Equity Q2 2012 · Dec 31, 2011 $84.12M
Current Liabilities Q2 2012 · Jun 30, 2012 $31.18M
Current Liabilities Q2 2012 · Dec 31, 2011 $29.45M
Total Liabilities Q2 2012 · Jun 30, 2012 $33.55M
Total Liabilities Q2 2012 · Dec 31, 2011 $31.7M
Current Assets Q2 2012 · Jun 30, 2012 $69.37M
Current Assets Q2 2012 · Dec 31, 2011 $71.74M
Total Assets Q2 2012 · Jun 30, 2012 $119.96M
Total Assets Q2 2012 · Dec 31, 2011 $115.82M
Shares Diluted Q2 2012 · Jun 30, 2011 33.75M sh
Shares Diluted Q2 2012 · Jun 30, 2011 33.71M sh
Stock Repurchased Q2 2012 · Jun 30, 2011 $14K
Capex Q2 2012 · Jun 30, 2011 $608K
Capex Q2 2012 · Jun 30, 2011 $1.3M
Cash And Equivalents Q2 2012 · Jun 30, 2011 $28.33M
Cash And Equivalents Q2 2012 · Dec 31, 2010 $29.67M
Eps Diluted Q2 2012 · Jun 30, 2011 $0.04
Eps Diluted Q2 2012 · Jun 30, 2011 $0.05
Eps Basic Q2 2012 · Jun 30, 2011 $0.04
Eps Basic Q2 2012 · Jun 30, 2011 $0.05
Sga Expense Q2 2012 · Jun 30, 2011 $5.55M
Sga Expense Q2 2012 · Jun 30, 2011 $11.39M
Rd Expense Q2 2012 · Jun 30, 2011 $460K
Rd Expense Q2 2012 · Jun 30, 2011 $995K
Net Income Q2 2012 · Jun 30, 2011 $1.19M
Net Income Q2 2012 · Jun 30, 2011 $1.64M
Operating Income Q2 2012 · Jun 30, 2011 $2M
Operating Income Q2 2012 · Jun 30, 2011 $2.89M
Gross Profit Q2 2012 · Jun 30, 2011 $8.71M
Gross Profit Q2 2012 · Jun 30, 2011 $16.68M
Cost Of Revenue Q2 2012 · Jun 30, 2011 $12.83M
Cost Of Revenue Q2 2012 · Jun 30, 2011 $25.11M